Latest Market Segmentation News

Perpetual Limited reported a robust first quarter for FY26, with growth across its Asset Management, Corporate Trust, and Wealth Management divisions, driven by strong market returns and strategic initiatives.

EROAD pivots strategically to prioritise ANZ electronic road user charging opportunities, revises FY26 guidance downward, and appoints John Scott as Executive Chair to steer growth.

Navigator Global Investments reports a 3% rise in total assets under management to USD 87 billion, driven by strong growth in Lighthouse Partners and private markets despite a challenging investment landscape.

Ionic Rare Earths Limited’s IXRO securities have been suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

Hydralyte USA reports an 11% sales increase in Q3 2025, driven by strong summer demand and the launch of its innovative Hydralyte Plus Brain Support product featuring nootropics.

VEEM Limited has completed a $14 million placement to accelerate its growth in the defence sector, highlighted by a new 9-year manufacturing licence agreement with Northrop Grumman valued initially at US$33 million. This positions VEEM alongside major US defence contractors and signals a significant step into the expanding submarine and naval supply chains.

Simble Solutions has landed a significant three-year contract to deploy its SimbleSense energy intelligence platform across more than 60 UK forecourt sites operated by Ascona Group. This deal underscores Simble’s expanding footprint in the UK energy management sector and supports Ascona’s ambitious net-zero goals.

Finbar Group has launched its $115 million Riverbank Residences project with over 70% of apartments sold, while August sales hit a 30-year high, signalling strong demand for mid-tier Perth apartments.

IperionX has boosted its titanium powder capacity by 60% with no extra capital, cutting unit costs to $55/kg, and is now accelerating a US Department of Defense-backed expansion to 1,400 tpa aiming for the lowest-cost titanium production in America.

Lumos Diagnostics, backed by BARDA, is set to begin a pivotal pediatric clinical study to extend the use of its rapid respiratory infection test, FebriDx, to children aged 2–12 in U.S. CLIA-waived settings, potentially unlocking a $1 billion market.

Orbital Corporation Limited posted a $4.3 million net loss for FY25, reflecting a revenue decline amid production transitions. The company secured a $3 million capital raise to support new UAV engine development and expand its global footprint.

Volt Group Limited reported a 24% revenue decline and a net loss of $271,854 for the half year ended June 2025, primarily due to timing delays in Wescone orders and iron ore sector shutdowns. Despite this, the company advances its innovative ATEN waste heat to power technology and expands its EcoQuip solar light tower fleet, while initiating a 12-month on-market share buy-back.